Tumor necrosis factor alpha (TNFa) is an inflammatory cytokine that is present in the microenvironment of many tumors and is known to promote tumor progression. To examine how TNFa modulates the progression and metastasis of nasopharyngeal carcinoma, we used Affymetrix chips to identify TNFa-inducible genes that are dysregulated in this tumor. Elevated expression of TNFAIP2, which encodes TNFa-inducible protein 2 and not previously known to be associated with cancer, was found and confirmed by quantitative RT-PCR of TNFAIP2 expression in nasopharyngeal carcinoma and adjacent normal tissues. Immunohistochemical analysis showed that the TNFAIP2 protein was highly expressed in tumor cells. Analysis of 95 nasopharyngeal carcinoma biopsy specimens revealed that high TNFAIP2 expression was significantly correlated with highlevel intratumoral microvessel density (P ¼ 0.005) and low distant metastasis-free survival (P ¼ 0.001). A multivariate analysis further confirmed that TNFAIP2 was an independent prognostic factor for nasopharyngeal carcinoma (P ¼ 0.002). In vitro, TNFa treatment of nasopharyngeal carcinoma HK1 cells was found to induce TNFAIP2 expression, and siRNA-based knockdown of TNFAIP2 dramatically reduced the migration and invasion of nasopharyngeal carcinoma HK1 cells. These results collectively suggest for the first time that TNFAIP2 is a cell migration-promoting protein and its expression predicts distant metastasis. Our data suggest that TNFAIP2 may serve as an independent prognostic indicator for nasopharyngeal carcinoma.
Tumor necrosis factor alpha (TNFa), a major inflammatory cytokine in the tumor microenvironment, is produced by both malignant and non-cancerous cells, 1, 2 and has been shown to mediate cancerrelated inflammation and promote tumor progression by enhancing angiogenesis and metastasis. 3 Increased TNFa levels in the tumor microenvironment and plasma have been associated with poor prognosis in various cancers, including prostate cancer, 4 breast cancer, 5 and nasopharyngeal carcinoma. 6, 7 However, the mechanisms through which TNFa increases tumor progression have not yet been fully defined. Nasopharyngeal carcinoma is a highly metastatic head and neck cancer that is relatively rare among Caucasians, but is common in southeastern China and in Taiwan. 8 In Hong Kong, the incidence of nasopharyngeal carcinoma is as high as 20-30 per 100 000 in men and 15-20 per 100 000 in women. 8 According to data from the Cancer Registry of Taiwan, nasopharyngeal carcinoma is the ninth most common cancer, with an estimated incidence of B6 cases per 100 000 in 2002. Under the current treatment regimens, the survival rates among nasopharyngeal carcinoma patients are B92% at 1 year and B50% at 5 years, with 20-25% of patients eventually developing distant metastases. 9, 10 Nasopharyngeal carcinoma is generally sensitive to radiation therapy, but more advanced cases may require a combination of radiotherapy and chemotherapy. 11 Thus, it is essential for us to develop more effective diagnostic and therapeutic strategies against nasopharyngeal carcinoma.
In an effort to clarify the underlying mechanisms of malignancy in nasopharyngeal carcinoma, our group previously used Affymetrix-chip-based microarray hybridization to identify various nasopharyngeal carcinoma metastasis-associated biomarkers. We analyzed the various TNFa-regulated genes that appeared to be upregulated in nasopharyngeal carcinoma tumor cells vs adjacent normal tissues, and found differential expression of various TNFa target genes MMP9, 12 18 and thymidine phosphorylase. [19] [20] [21] We further showed that the upregulation of thymidine phosphorylase in nasopharyngeal carcinoma tumor cells resulted at least in part from cytoplasmic heterogeneous nuclear ribonucleoprotein K (hnRNP K)-mediated stabilization of the thymidine phosphorylase mRNA. 22 High levels of thymidine phosphorylase and cytoplasmic hnRNP K were significantly correlated with overall survival and distant metastasis. 19 On the basis of this success, we have continued to search for other TNFaregulated genes that could serve as potential biomarkers for nasopharyngeal carcinoma prognosis.
TNFAIP2 is also a TNFa-regulated gene that is expressed in endothelial cells, 23 peripheral blood monocytes, 24 and mature sperm. 24 Here we investigated TNFAIP2, which is found to be highly expressed at both the mRNA and protein levels in nasopharyngeal carcinoma tumor cells vs adjacent normal tissues. TNFAIP2 encodes a protein whose precise function is not known, but appears to be involved in endothelial capillary tube formation in vitro. 23 Although TNFAIP2 has been classified as an angiogenic factor, 23 its function and significance in tumor development have not previously been determined. Here, we show for the first time that increased expression of TNFAIP2 is significantly correlated with shorter distant metastasis-free survival in nasopharyngeal carcinoma patients, and that TNFAIP2 promotes the migration and invasion of nasopharyngeal carcinoma cells in vitro. These results suggest that TNFAIP2 may serve as a potential diagnostic and independent prognostic marker for nasopharyngeal carcinoma.
Materials and methods

Patients, Clinical Staging, Treatment, and Assessment of Clinical Outcome
The utilized retrospective cohort comprised 95 nasopharyngeal carcinoma patients who had been admitted to Chang Gung Memorial Hospital at Lin-Kou from 1990 to 2006. AJCC stage, T stage, and N stage were defined according to the 2002 cancer-staging system revised by the American Joint Committee on Cancer. Histological typing was performed according to the WHO classification criteria, as described previously. 19 This study was reviewed and approved by the institutional review board and ethics committee of Chang Gung Memorial Hospital. Informed consent was obtained from all patients.
All enrolled patients had been treated with definitive radiotherapy (cumulative dose of external beam radiotherapy 4R64.8 Gy). Among them, 33 patients had received additional chemotherapy in the Department of Medical Oncology at Chang Gung Memorial Hospital. Patients who presented with distant metastatic disease at diagnosis (M1 stage) and those who had undergone previous treatment at another institute were excluded from this study. For all enrolled patients, pathology reports were obtained from the pathological database and medical records, and the relevant slides were reviewed to confirm the nasopharyngeal carcinoma diagnosis (reviews were performed by C Hsueh). Clinical data on stage, treatment, and follow-up were collected from hospital tumor registries and medical files. The primary end point was disease-free survival, which was calculated from the date of diagnosis to the date of death or last follow-up. Distant metastasis-free survival and local recurrence-free survival were also assessed. The time to local recurrence or distant metastasis was calculated by using the date on which the local recurrence or distant metastasis was detected as the end point. Patients who died without local recurrence or distant metastasis were omitted from our analyses of disease-free survival, local recurrence-free survival, and distant metastasis-free survival.
Affymetrix Microarray Analysis
RNA samples from nasopharyngeal carcinoma tissues were isolated using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA). The biotinylated oligonucleotide was hybridized to the Human Genome U133 Plus 2.0 Array (Affymetrix, Santa Clara, CA, USA) by the National Yang-Ming University Genomics Center (Taiwan), following the manufacturer's instructions. The microarray data were analyzed using the GeneSpring version GX 7.31 software package (Silcogenetics, Redwood, CA, USA). The relative expression level of each gene was calculated as the ratio of the average hybridization intensity from nine individual nasopharyngeal carcinoma tissues vs that from a pool of the corresponding adjacent non-tumor tissues.
Immunohistochemical Staining Analysis
Immunohistochemical analyses were performed using an automatic immunohistochemical staining device according to the manufacturer's instructions (Bond-max Automated Immunostainer; Vision BioSystems, Melbourne, Australia). Tissue sections were retrieved using Bond Epitope Retrieval Solution 1 (Vision BioSystems) and stained with antibodies against TNFAIP2 (mouse monoclonal TNFAIP2 promotes metastasis antibody, 1:100 dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and CD34 (mouse monoclonal antibody, ready to use; DAKO, Glostrup, Denmark). A polymer detection system (Bond Polymer Refine; Vision BioSystems) was used to reduce nonspecific staining. Tissue sections were treated with liquid DAB reagent, using 3 0 -diaminobenzidine tetrahydrochloride as the chromogen and hematoxylin as the counterstaining reagent. The expression of TNFAIP2 was assessed by quantitative scoring of the staining intensity and the proportion of positively stained cells. Staining intensity was graded as 0, 1, 2, or 3 to indicate undetectable, weak, moderate, and strong staining, respectively. These scores were multiplied by the percentage of cells that showed positive staining; the resulting scores, which were taken as reflecting protein expression, were used to classify the specimens/patients into two groups: 'high-level' TNFAIP2 expression (scores 4120) and 'low-level' TNFAIP2 expression (scores r120). For assessment of intratumoral microvessel density, we stained sections using an antibody against CD34 (an endothelial marker). Microvessel density was determined from Â 100 microscopic fields within the tumor areas containing the most microvessels. Vessels were counted from four different Â 100 fields, and the averages were calculated. Specimens averaging more than 14 microvessels per field were defined as 'high microvessel density', while those averaging 14 or fewer were defined as 'low microvessel density'. TNFAIP2-positive tumor cells and microvessel density in representative microscopic fields were scored independently by two experienced pathologists.
Quantitative RT-PCR
RNA samples from nasopharyngeal carcinoma tissues and HK1 cells were isolated using the TRIzol reagent (Invitrogen). Reverse transcription of RNA (1 mg) was performed using an ImProm-II kit (Promega, Madison, WI, USA) and oligo(dT) 15 primers (Promega). The primers used to amplify the cDNA corresponding to TNFAIP2 were as follows: forward primer, 5 0 -CCTGCTCTCCCTACGC-3 0 ; and reverse primer, 5 0 -CGTCCAAGATGCTCCG-3 0 . The primers used to amplify the GAPDH cDNA were as described previously. 22 Quantitative RT-PCR was performed on a Light-Cycler (Roche Diagnostics, Mannheim, Germany), according to the manufacturer's instructions, using the FastStart DNA Master SYBR Green I reagent (Roche Diagnostics). The gene expression results were normalized with regard to the expression of GADPH.
Cell Culture
HK1 cells (a nasopharyngeal carcinoma cell line) were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin at 371C under 5% CO 2 .
Western Blotting
Whole-cell lysates were prepared by suspending cells in NP40 lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Igepal CA-630, 1 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mg/ml pepstatin, and 1 mM phenylmethylsulfonyl fluoride). The samples were incubated on ice for 30 min, the resulting lysates were centrifuged at 12 000 g at 41C for 10 min, and the supernatants were retained. The protein concentrations in the clarified lysates were determined using the Bradford reagent. Equal amounts of protein (30 mg) were resolved by electrophoresis on 10% SDSpolyacrylamide gels, and transferred to nitrocellulose membranes. The membranes were blocked with 5% non-fat dry milk in TBS-Tween 20, and then incubated at room temperature for 2 h with primary anti-TNFAIP2 and anti-tubulin antibodies (Santa Cruz Biotechnology). The membranes were subsequently incubated with secondary antibodies coupled to horseradish peroxidase and the results were visualized using ECL detection reagents (Amersham Pharmacia Biotech, Arlington Heights, IL, USA).
RNA Interference
HK1 cells (4 Â 10 5 ) were plated on six-well plates and transfected using 50 nmol/l dsRNA duplexes and 50 mg dsRNA transfection reagents (TransIT-TKO; Mirus Bio, Madison, WI, USA), according to the manufacturer's protocol. SMARTpool reagents containing a mixture of four 21-bp RNA TNFAIP2-targeting duplexes were purchased from Dharmacon (Lafayette, CO, USA), whereas the negative control siRNA were synthesized by Research Biolabs (Ayer Rajah Industrial Estate, Singapore). The TNFAIP2-targeting oligonucleotide sequences were as follows:
Cell Proliferation Assay
Cells were subjected to dsRNA transfection with control or TNFAIP2-targeting siRNAs, and total cell numbers were counted on days 1, 2, and 3 after transfection. Duplicate experiments were performed at least three independent times.
ELISA Assay
Cells were subjected to dsRNA transfection. At 48 h post-transfection, the transfection medium was replaced with complete medium. After 24 h, the conditioned media were collected and centrifuged at 1500 r.p.m. for 5 min. The resulting pellets were discarded and the supernatants were tested for vascular endothelial growth factor (VEGF) expression using the Quantikine Human VEGF Immunoassay (R & D Systems, Minneapolis, MN, USA), according to the manufacturer's instructions.
Cell Migration and Invasion Assays
The migration and invasion of HK1 cells were evaluated using a chemotaxis chamber (Corning, Corning, NY, USA) and a Cell Invasion Assay Kit (Chemicon, Temecula, CA, USA), respectively. HK1 cells that had been transfected with the dsRNA were washed twice with serum-free medium, resuspended in 100 ml of serum-free medium, and added to the upper chamber of the apparatus. The lower chamber contained 10% FBS medium. For the migration and invasion assays, the cells were incubated for 24 and 72 h, respectively. The migrated and invasive cells were fixed and stained for 15 min with 0.25% crystal violet, 10% formaldehyde, and 80% methanol, and then the filters were washed five times with ddH 2 O for the removal of non-adherent cells. Ten random fields ( Â 100 magnification) were captured for each membrane, and the migrated or invasive cells were counted.
Statistical Analysis
All statistical analyses were performed using the SPSS 13.0 statistical software package (SPSS, Chicago, IL, USA). The relationships between TNFAIP2 expression and the microvessel density and various clinicopathological characteristics were evaluated using the Pearson w 2 test. Survival curves were plotted using the Kaplan-Meier method and compared using the log-rank test. The Cox proportional hazards model was applied for multivariate analysis to determine the independence of each prognostic factor. The cutoff values used to define high TNFAIP2 and microvessel density were based on the percentages of TNFAIP2 staining in tumor cells and average microvessel numbers, as determined from receiver operating characteristic curve analysis. The in vitro data were analyzed with the twotailed paired Student's t-test. The data shown represent the mean±s.d. or mean±s.e.m., as indicated.
Results
Affymetrix Analysis of TNFa-Inducible Genes in Nasopharyngeal Carcinoma
TNFa mediates cancer-related inflammation, and may promote tumor progression by increasing angiogenesis and metastasis. [1] [2] [3] 25 In an effort to identify genes that may be involved in TNFaresponsive malignant progression, we used the Affymetrix HG U133 Plus 2.0 chip to perform systematic microarray expression profiling on nine This list of probe IDs of Human Genome U133 Plus 2.0 Array, which correspond to the top 10 of increased TNFa-inducible response genes among total 1289 genes with more than twofold changes and P-valueo0.001 between the nasopharyngeal carcinoma (n ¼ 9) and a pooled normal. TNFAIP2 mRNA expression in nasopharyngeal carcinoma specimens. Quantitative RT-PCR was used to examine the relative mRNA expression levels in nine nasopharyngeal carcinoma tissues and pooled adjacent normal tissues, and the results were normalized with regard to GAPDH expression. All data are presented as the mean ± s.e.m. (c-j) Consecutive nasopharyngeal carcinoma tissue sections were stained using anti-TNFAIP2 and anti-CD34 antibodies, and subjected to immunohistochemical analysis. Images were taken at Â 100 magnification (c, e, g and i) and Â 400 magnification (d, f, h and j). Elevated TNFAIP2 expression was observed primarily in tumor cells, whereas no or weak expression was seen in normal epithelium. Representative images of tumor cells with high (c and d) and low (e and f) CD34 expression and with high (g and h) and low (i and j) microvessel density are shown. The sample shown contains normal epithelium (N) and stroma (S), and the tumor (T), as indicated. The boxed areas depict Â 400 magnification; bars ¼ 100 mM. 14 Consistent with our previous findings, c-FLIP 29 and thymidine phosphorylase 19 were also significantly increased, by 2.26-fold (208485_x_at) and 3.46-fold (204858_s_at), respectively. From the highly upregulated genes, we chose to further explore TNFAIP2, as the expression, biological function, and potential pathological significance of this gene and its encoded protein had not been previously explored in the context of nasopharyngeal carcinoma or other cancers.
TNFAIP2 is Regulated by TNFa, and Its Expression is Correlated with Microvessel Density in Nasopharyngeal Carcinoma
Although TNFAIP2 was originally identified as a gene that was rapidly induced by TNFa treatment of endothelial cells, 23 its regulation in nasopharyngeal carcinoma cells had not been studied previously. Accordingly, we first examined the effect of TNFa on the expression of TNFAIP2 in a nasopharyngeal carcinoma cell line (HK1 cells). As shown in Figure 1a , the mRNA and protein levels of TNFAIP2 were induced by 3.8-and 2.3-fold, respectively, in TNFa-treated cells compared with control cells. This suggests that TNFAIP2 could be induced by TNFa treatment of nasopharyngeal carcinoma cells.
To confirm the elevated expression of TNFAIP2 in nasopharyngeal carcinoma, we used quantitative RT-PCR to examine the levels of TNFAIP2 mRNA in RNA purified from nasopharyngeal carcinoma tissues. As shown in Figure 1b , the mRNA levels of TNFAIP2 were significantly elevated (by 13.7-fold) in nasopharyngeal carcinoma tissues vs adjacent normal tissues. We further used immunohistochemical staining with an anti-TNFAIP2 antibody to examine TNFAIP2 protein expression in 95 nasopharyngeal carcinoma biopsy specimens. We detected high-level expression of TNFAIP2 in 39% of the samples, and low-level expression in 61% (Figures 1c-f and Table 2 ). In contrast, TNFAIP2 expression was found to be undetectable or very weak in normal nasopharyngeal epithelial and stromal cells (Figures 1c and d) .
As TNFAIP2 expression has been correlated with endothelial capillary tube formation in vitro, 23 we further used immunohistochemical staining with an antibody against CD34 (an endothelial marker) to analyze the potential correlation of TNFAIP2 with intratumoral microvessel density. As shown in Figures 1g-j and Table 2 , 60 (63%) and 35 (37%) of the samples showed high and low levels of microvessel density, respectively. Statistical analysis of the nasopharyngeal carcinoma expression data using the Pearson w 2 test showed that TNFAIP2 expression was positively correlated with microvessel density (Table 2 ; Po0.005).
Patient Characteristics and TNFAIP2
To evaluate the prognostic significance of TNFAIP2 under current therapeutic protocols, we studied the clinical outcomes among our cohort of 95 nasopharyngeal carcinoma patients. The patient characteristics and clinical features are summarized in Table 2 . The median age at diagnosis was 45 years (range, 13.6-73.4 years), with a male-to-female ratio of B3:1. The clinicopathological features were comparable between the classified patient subgroups. No significant correlation was found between TNFAIP2 expression and age, gender, N stage, AJCC stage, or chemotherapy. Notably, however, TNFAIP2 expression was significantly associated with the extent of the primary tumor designated as T stage.
Association of TNFAIP2 with Distant Metastasis-free Survival
Kaplan-Meier survival analysis was used to compare disease-free survival, local recurrence-free survival, and distant metastasis-free survival between patients with high and low TNFAIP2 positivity. As shown in Figure 2 , we found a significant difference in distant metastasis-free survival between patients with high and low TNFAIP2 (P ¼ 0.001), whereas there was no statistical difference for disease-free survival or local recurrence-free survival (P ¼ 0.488 and 0.581, respectively). Among the 95 patients, 37 and 58 patients showed high and low TNFAIP2 expression, respectively, in their tumor cells. In the high expression group, 15 of 37 patients developed distant metastases after the initial radiotherapy (40.5%), whereas this proportion was only seven of 58 in the low expression group (12.1%). Thus, the expression level of TNFAIP2 was significantly correlated with distant metastasis-free survival (P ¼ 0.001) in nasopharyngeal carcinoma patients. We next conducted a multivariate analysis of TNFAIP2 expression level with age, gender, T stage, N stage, chemotherapy, and microvessel density. Our results indicated that TNFAIP2 and N stage were independent prognostic predictors of poor distant metastasis-free survival (P ¼ 0.002 and 0.036, respectively; Table 3 ).
Promotion of Cell Migration and Invasion by TNFAIP2
As our results indicated that TNFAIP2 overexpression was correlated with intratumoral angiogenesis and distant metastasis in nasopharyngeal carcinoma patients, we next examined its biological functions in nasopharyngeal carcinoma HK1 cells, using RNA interference technology. First, we analyzed the effects of TNFAIP2 knockdown on the migration and invasion (two processes that are critical to distant metastasis) of HK1 cells. As shown in Figures 3a and b , TNFAIP2-knockdown cells showed significant reductions in cell migration and invasion, suggesting that TNFAIP2 may be involved in the migration and invasion of tumor cells. We then characterized the effect of TNFAIP2 knockdown on cell growth. As shown in Figure 3c , growth was not significantly different between TNFAIP2-knockdown and control siRNA-transfected HK1 cells, suggesting that TNFAIP2 does not affect tumor growth. Finally, we tested for a potential interaction between TNFAIP2 and VEGF, an important secreted angiogenesis-initiating factor that has also been correlated with microvessel density in nasopharyngeal carcinoma patients. 30 As the protein sequence of TNFAIP2 (amino acids 91-651) is highly similar to that of SEC6 (based on a publicly available website http://www.sanger.ac.uk/), an exocyst complex component involved in exocytosis 31 and secretion, 32 we examined whether TNFAIP2 affected the secretion of VEGF by HK1 cells. As shown in Figure 3d , our results revealed that VEGF secretion by HK1 cells was not affected by TNFAIP2 knockdown. These findings indicate that the effect of TNFAIP2 on tumor cells may not be mediated via VEGF secretion, and that VEGF secretion in tumor cells does not appear to be regulated by TNFAIP2. TNFAIP2 promotes metastasis
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Discussion
This is the first report to show that TNFAIP2, which had previously been reported as a TNFa-inducible protein, is highly expressed in nasopharyngeal carcinoma cells and is significantly correlated with intratumoral microvessel density and shorter distant metastasis-free survival in nasopharyngeal carcinoma patients. TNFAIP2 may therefore have the potential as an independent prognostic indicator for nasopharyngeal carcinoma. Importantly, we also herein find a novel role for TNFAIP2, by showing that it promotes the migration and invasion of nasopharyngeal carcinoma cells in vitro. This may explain the correlation of TNFAIP2 with the extent of tumor and distant metastasis-free survival in nasopharyngeal carcinoma patients. In the tumor microenvironment, TNFa mediates cancer-related inflammation, and may promote tumor progression by increasing angiogenesis and metastasis. [1] [2] [3] 25 The levels of TNFa [6] [7] and its downstream genes c-FLIP 18, 29 and thymidine phosphorylase [19] [20] [21] [22] are known to be elevated in nasopharyngeal carcinoma tumor tissues. Here, we used Affymetrix chips to identify the 10 TNFa-inducible genes showing the highest upregulation in nasopharyngeal carcinoma tissues vs normal adjacent tissues. Among them, we identified one gene that had not previously been examined in the context of cancer: TNFAIP2. The previous reports and our present findings collectively suggest that TNFAIP2 contributes to the tumor-promoting effects of TNFa. This hypothesis is supported by our present findings that: (1) TNFAIP2 was induced by TNFa treatment of nasopharyngeal carcinoma cells; (2) silencing of TNFAIP2 by siRNA-mediated knockdown significantly reduced the migration and invasion of HK1 cells (Figures 3a and b) ; and (3) TNFAIP2 expression levels were significantly correlated with shorter distant metastasis-free survival TNFAIP2 promotes metastasis among 95 nasopharyngeal carcinoma patients. Taken together, these results suggest that the pro-tumor activity of TNFa in nasopharyngeal carcinoma is mediated at least in part through TNFAIP2.
TNFa has been shown to promote vascularization in rabbit cornea and chick chorioallantoic membrane, 33, 34 and to induce the expression of various angiogenic factors, including VEGF. [35] [36] [37] Furthermore, VEGF expression was found to be markedly increased and correlated with microvessel density in nasopharyngeal carcinoma patients. 30 Similarly, we herein found that TNFAIP2 is a downstream target of TNFa that acts as a potential angiogenic factor, as shown by the association of its expression with microvessel density in vivo.
The amino-acid sequence of TNFAIP2 is similar to that of SEC6, which is involved in exocytosis 31 and secretion. 32 Therefore, we hypothesized that TNFAIP2 could promote angiogenesis by upregulating VEGF secretion. However, we did not observe any decrease in VEGF secretion by TNFAIP2-knockdown HK1 cells (Figure 3d ), suggesting that TNFAIP2 is not involved in the regulation of VEGF secretion. As the regulatory network responsible for modulating angiogenesis is remarkably complex, further studies will be needed to clarify how TNFAIP2 affects angiogenesis in nasopharyngeal carcinoma.
TNFAIP2 has previously been shown to be regulated by interleukin-1b (IL-1b), 23 retinoic acid, 38 erythroblastic leukemia viral oncogene homolog 2 (V-erb-b2), 39 and dioxin. 40 In the clinical setting, the levels of TNFa and IL-1b are known to be elevated in nasopharyngeal carcinoma. 6, 7, 41 Thus, the dysregulation of TNFAIP2 expression in the nasopharyngeal carcinoma microenvironment may result from the combined effects of TNFa and IL-1b, which may promote tumor progression (eg, distant metastasis and angiogenesis) by inducing TNFAIP2.
In summary, we herein identify a novel role for TNFAIP2 by showing that it promotes the migration and invasion of nasopharyngeal carcinoma tumor cells. Moreover, we show that TNFAIP2 expression appears to be an independent prognostic marker for distant metastasis in nasopharyngeal carcinoma patients, and therefore might be a useful therapeutic indicator for these high-risk nasopharyngeal carcinoma patients to receive concurrent chemoradiotherapy.
